Changes in Sub. S-hldr’s Int (Section 138 of CA 2016)
Particulars of substantial Securities Holder
| Name |
DR IHSAN BIN OSMAN |
| Nationality/Country of incorporation |
Malaysia |
| Descriptions (Class) |
Ordinary Shares |
Details of changes
| No |
Date of change |
No of securities |
Type of Transaction |
Nature of Interest |
| 1 |
08 Oct 2018 |
85,000 |
Acquired |
Indirect Interest |
|
Name of registered holder |
REZWAN BIN IHSAN |
| Address of registered holder |
BT 21 KG AIR HITAM DARAT 78300 MASJID TANAH MELAKA |
|
Description of “Others” Type of Transaction |
|
|
|
|
|
|
| Circumstances by reason of which change has occurred |
Acquisition of shares via open market |
| Nature of interest |
Indirect Interest |
| Direct (units) |
4,331,450 |
| Direct (%) |
5.289 |
| Indirect/deemed interest (units) |
4,080,800 |
| Indirect/deemed interest (%) |
4.983 |
| Total no of securities after change |
8,412,250 |
| Date of notice |
10 Oct 2018 |
| Date notice received by Listed Issuer |
10 Oct 2018 |
|
Remarks : |
| Acquisition of 85,000 shares by Mr Rezwan Bin Ihsan via open market, which Dr Ihsan Bin Osman is deemed interest pursuant to Section 8 of the Companies Act 2016. |
OTHERS MESB BERHAD – EXTENSION OF TIME FOR THE UTILISATION OF PROCEEDS ARISING FROM THE PRIVATE PLACEMENT
Amended Announcements
Please refer to the earlier announcement reference number: GA1-05102018-00087
| Type |
Announcement |
| Subject |
OTHERS |
| Description |
MESB BERHAD – EXTENSION OF TIME FOR THE UTILISATION OF PROCEEDS ARISING FROM THE PRIVATE PLACEMENT |
| Reference is made to the announcements of MESB Berhad (“the Company” or “MESB”) dated 9 October 2017 and 5 October 2018 in relation to the completion of the private placement of 12,600,000 new ordinary shares of RM0.73 each in MESB (“Placement Shares”) to independent third party investors (“Private Placement”).
In relation to the announcement dated 5 October 2018, the additional and amended information is and highlighted below:-
Details on the Intended/Extended Timeframe
| Purpose |
Proposed Utilisation (RM’000) |
Variance (ii) (RM’000) |
Actual Utilisation (RM’000) |
Balance unutilised as at 4 October 2018 (RM’000) |
Intended timeframe for utilisation
|
Extended timeframe for utilisation
|
| Working capital |
2,498 |
+32(ii) |
(2,530) |
– |
Within 6 months from the completion of the Private Placement
|
– |
| Business expansion |
6,500 |
– |
(5,565) |
935(i) |
Within 12 months from the completion of the Private Placement
|
Within 12 months from 8 October 2018 to 9 October 2019 |
| Expenses related to the Private Placement |
200 |
(32)(ii) |
(168) |
– |
Within 1 month from the completion of the Private Placement
|
– |
| Total |
9,198 |
– |
(8,263) |
935 |
|
(i) the balance proceeds is expected to be fully utilised within the extended timeframe.
(ii) As stated in the Circular to Shareholders dated 12 September 2017 in relation to Private Placement, if the actual expenses relating to the Private Placement are lower than the estimated amount i.e. RM200,000, the excess will be utilised for working capital purposes. The actual expenses for the Private Placement was RM168,000 and the excess of RM32,000 has been fully utilised for working capital on 21 September 2018.
The Board after having considered the existing progress of Group’s business expansion in the new product line, has decided to extend the time frame for the utilisation of the balance proceeds of RM935,000.
Accordingly, the Board wish to announce that it had on 5 October 2018 approved an extension of time of 12 months until 9 October 2019 for the utilisation of the aforesaid balance proceeds.
The extension of time for the utilisation of the balance of the proceeds is not subjected to shareholders’ or regulatory’ approvals.
This announcement is dated 10 October 2018 |
